United States Pharma Ophthalmic Market Report 2018

February 2018 | 103 pages | ID: U77B275BEBFEN
QYResearch

Abstracts

In this report, the United States Pharma Ophthalmic market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Pharma Ophthalmic in these regions, from 2013 to 2025 (forecast).

United States Pharma Ophthalmic market competition by top manufacturers/players, with Pharma Ophthalmic sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis
• Allergan
• Roche
• Valeant
• Regeneron
• Santen
• Bayer
• Pfizer
• Senju
• Akorn

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Retinal disorders drugs
• Allergic, inflammatory and infective drugs
• Glaucoma drugs
• Dry eye drugs
• Other ophthalmic drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Glaucoma
• Dry eye syndrome
• Retinal diseases
• Other ophthalmic indications

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Pharma Ophthalmic Market Report 2018

1 PHARMA OPHTHALMIC OVERVIEW

1.1 Product Overview and Scope of Pharma Ophthalmic
1.2 Classification of Pharma Ophthalmic by Product Category
  1.2.1 United States Pharma Ophthalmic Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Pharma Ophthalmic Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Retinal disorders drugs
  1.2.4 Allergic, inflammatory and infective drugs
  1.2.5 Glaucoma drugs
  1.2.6 Dry eye drugs
  1.2.7 Other ophthalmic drugs
1.3 United States Pharma Ophthalmic Market by Application/End Users
  1.3.1 United States Pharma Ophthalmic Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Glaucoma
  1.3.3 Dry eye syndrome
  1.3.4 Retinal diseases
  1.3.5 Other ophthalmic indications
1.4 United States Pharma Ophthalmic Market by Region
  1.4.1 United States Pharma Ophthalmic Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Pharma Ophthalmic Status and Prospect (2013-2025)
  1.4.3 Southwest Pharma Ophthalmic Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Pharma Ophthalmic Status and Prospect (2013-2025)
  1.4.5 New England Pharma Ophthalmic Status and Prospect (2013-2025)
  1.4.6 The South Pharma Ophthalmic Status and Prospect (2013-2025)
  1.4.7 The Midwest Pharma Ophthalmic Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Pharma Ophthalmic (2013-2025)
  1.5.1 United States Pharma Ophthalmic Sales and Growth Rate (2013-2025)
  1.5.2 United States Pharma Ophthalmic Revenue and Growth Rate (2013-2025)

2 UNITED STATES PHARMA OPHTHALMIC MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Pharma Ophthalmic Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Pharma Ophthalmic Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Pharma Ophthalmic Average Price by Players/Suppliers (2013-2018)
2.4 United States Pharma Ophthalmic Market Competitive Situation and Trends
  2.4.1 United States Pharma Ophthalmic Market Concentration Rate
  2.4.2 United States Pharma Ophthalmic Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Pharma Ophthalmic Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PHARMA OPHTHALMIC SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Pharma Ophthalmic Sales and Market Share by Region (2013-2018)
3.2 United States Pharma Ophthalmic Revenue and Market Share by Region (2013-2018)
3.3 United States Pharma Ophthalmic Price by Region (2013-2018)

4 UNITED STATES PHARMA OPHTHALMIC SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Pharma Ophthalmic Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Pharma Ophthalmic Revenue and Market Share by Type (2013-2018)
4.3 United States Pharma Ophthalmic Price by Type (2013-2018)
4.4 United States Pharma Ophthalmic Sales Growth Rate by Type (2013-2018)

5 UNITED STATES PHARMA OPHTHALMIC SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Pharma Ophthalmic Sales and Market Share by Application (2013-2018)
5.2 United States Pharma Ophthalmic Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES PHARMA OPHTHALMIC PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Pharma Ophthalmic Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Allergan
  6.2.2 Pharma Ophthalmic Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Allergan Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Roche
  6.3.2 Pharma Ophthalmic Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Roche Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Valeant
  6.4.2 Pharma Ophthalmic Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Valeant Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Regeneron
  6.5.2 Pharma Ophthalmic Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Regeneron Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Santen
  6.6.2 Pharma Ophthalmic Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Santen Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Bayer
  6.7.2 Pharma Ophthalmic Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Bayer Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Pfizer
  6.8.2 Pharma Ophthalmic Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Pfizer Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Senju
  6.9.2 Pharma Ophthalmic Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Senju Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Akorn
  6.10.2 Pharma Ophthalmic Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Akorn Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview

7 PHARMA OPHTHALMIC MANUFACTURING COST ANALYSIS

7.1 Pharma Ophthalmic Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pharma Ophthalmic

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Pharma Ophthalmic Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pharma Ophthalmic Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PHARMA OPHTHALMIC MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Pharma Ophthalmic Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Pharma Ophthalmic Sales Volume Forecast by Type (2018-2025)
11.3 United States Pharma Ophthalmic Sales Volume Forecast by Application (2018-2025)
11.4 United States Pharma Ophthalmic Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Pharma Ophthalmic
Figure United States Pharma Ophthalmic Market Size (K Pcs) by Type (2013-2025)
Figure United States Pharma Ophthalmic Sales Volume Market Share by Type (Product Category) in 2017
Figure Retinal disorders drugs Product Picture
Figure Allergic, inflammatory and infective drugs Product Picture
Figure Glaucoma drugs Product Picture
Figure Dry eye drugs Product Picture
Figure Other ophthalmic drugs Product Picture
Figure United States Pharma Ophthalmic Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Pharma Ophthalmic by Application in 2017
Figure Glaucoma Examples
Table Key Downstream Customer in Glaucoma
Figure Dry eye syndrome Examples
Table Key Downstream Customer in Dry eye syndrome
Figure Retinal diseases Examples
Table Key Downstream Customer in Retinal diseases
Figure Other ophthalmic indications Examples
Table Key Downstream Customer in Other ophthalmic indications
Figure United States Pharma Ophthalmic Market Size (Million USD) by Region (2013-2025)
Figure The West Pharma Ophthalmic Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Pharma Ophthalmic Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Pharma Ophthalmic Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Pharma Ophthalmic Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Pharma Ophthalmic Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Pharma Ophthalmic Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Pharma Ophthalmic Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Pharma Ophthalmic Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Pharma Ophthalmic Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Pharma Ophthalmic Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Pharma Ophthalmic Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Pharma Ophthalmic Sales Share by Players/Suppliers
Figure 2017 United States Pharma Ophthalmic Sales Share by Players/Suppliers
Figure United States Pharma Ophthalmic Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Pharma Ophthalmic Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Pharma Ophthalmic Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Pharma Ophthalmic Revenue Share by Players/Suppliers
Figure 2017 United States Pharma Ophthalmic Revenue Share by Players/Suppliers
Table United States Market Pharma Ophthalmic Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Pharma Ophthalmic Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Pharma Ophthalmic Market Share of Top 3 Players/Suppliers
Figure United States Pharma Ophthalmic Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Pharma Ophthalmic Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Pharma Ophthalmic Product Category
Table United States Pharma Ophthalmic Sales (K Pcs) by Region (2013-2018)
Table United States Pharma Ophthalmic Sales Share by Region (2013-2018)
Figure United States Pharma Ophthalmic Sales Share by Region (2013-2018)
Figure United States Pharma Ophthalmic Sales Market Share by Region in 2017
Table United States Pharma Ophthalmic Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Pharma Ophthalmic Revenue Share by Region (2013-2018)
Figure United States Pharma Ophthalmic Revenue Market Share by Region (2013-2018)
Figure United States Pharma Ophthalmic Revenue Market Share by Region in 2017
Table United States Pharma Ophthalmic Price (USD/Pcs) by Region (2013-2018)
Table United States Pharma Ophthalmic Sales (K Pcs) by Type (2013-2018)
Table United States Pharma Ophthalmic Sales Share by Type (2013-2018)
Figure United States Pharma Ophthalmic Sales Share by Type (2013-2018)
Figure United States Pharma Ophthalmic Sales Market Share by Type in 2017
Table United States Pharma Ophthalmic Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Pharma Ophthalmic Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Pharma Ophthalmic by Type (2013-2018)
Figure Revenue Market Share of Pharma Ophthalmic by Type in 2017
Table United States Pharma Ophthalmic Price (USD/Pcs) by Types (2013-2018)
Figure United States Pharma Ophthalmic Sales Growth Rate by Type (2013-2018)
Table United States Pharma Ophthalmic Sales (K Pcs) by Application (2013-2018)
Table United States Pharma Ophthalmic Sales Market Share by Application (2013-2018)
Figure United States Pharma Ophthalmic Sales Market Share by Application (2013-2018)
Figure United States Pharma Ophthalmic Sales Market Share by Application in 2017
Table United States Pharma Ophthalmic Sales Growth Rate by Application (2013-2018)
Figure United States Pharma Ophthalmic Sales Growth Rate by Application (2013-2018)
Table Novartis Basic Information List
Table Novartis Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novartis Pharma Ophthalmic Sales Growth Rate (2013-2018)
Figure Novartis Pharma Ophthalmic Sales Market Share in United States (2013-2018)
Figure Novartis Pharma Ophthalmic Revenue Market Share in United States (2013-2018)
Table Allergan Basic Information List
Table Allergan Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Allergan Pharma Ophthalmic Sales Growth Rate (2013-2018)
Figure Allergan Pharma Ophthalmic Sales Market Share in United States (2013-2018)
Figure Allergan Pharma Ophthalmic Revenue Market Share in United States (2013-2018)
Table Roche Basic Information List
Table Roche Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Roche Pharma Ophthalmic Sales Growth Rate (2013-2018)
Figure Roche Pharma Ophthalmic Sales Market Share in United States (2013-2018)
Figure Roche Pharma Ophthalmic Revenue Market Share in United States (2013-2018)
Table Valeant Basic Information List
Table Valeant Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Valeant Pharma Ophthalmic Sales Growth Rate (2013-2018)
Figure Valeant Pharma Ophthalmic Sales Market Share in United States (2013-2018)
Figure Valeant Pharma Ophthalmic Revenue Market Share in United States (2013-2018)
Table Regeneron Basic Information List
Table Regeneron Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Regeneron Pharma Ophthalmic Sales Growth Rate (2013-2018)
Figure Regeneron Pharma Ophthalmic Sales Market Share in United States (2013-2018)
Figure Regeneron Pharma Ophthalmic Revenue Market Share in United States (2013-2018)
Table Santen Basic Information List
Table Santen Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Santen Pharma Ophthalmic Sales Growth Rate (2013-2018)
Figure Santen Pharma Ophthalmic Sales Market Share in United States (2013-2018)
Figure Santen Pharma Ophthalmic Revenue Market Share in United States (2013-2018)
Table Bayer Basic Information List
Table Bayer Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bayer Pharma Ophthalmic Sales Growth Rate (2013-2018)
Figure Bayer Pharma Ophthalmic Sales Market Share in United States (2013-2018)
Figure Bayer Pharma Ophthalmic Revenue Market Share in United States (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Pfizer Pharma Ophthalmic Sales Growth Rate (2013-2018)
Figure Pfizer Pharma Ophthalmic Sales Market Share in United States (2013-2018)
Figure Pfizer Pharma Ophthalmic Revenue Market Share in United States (2013-2018)
Table Senju Basic Information List
Table Senju Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Senju Pharma Ophthalmic Sales Growth Rate (2013-2018)
Figure Senju Pharma Ophthalmic Sales Market Share in United States (2013-2018)
Figure Senju Pharma Ophthalmic Revenue Market Share in United States (2013-2018)
Table Akorn Basic Information List
Table Akorn Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Akorn Pharma Ophthalmic Sales Growth Rate (2013-2018)
Figure Akorn Pharma Ophthalmic Sales Market Share in United States (2013-2018)
Figure Akorn Pharma Ophthalmic Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pharma Ophthalmic
Figure Manufacturing Process Analysis of Pharma Ophthalmic
Figure Pharma Ophthalmic Industrial Chain Analysis
Table Raw Materials Sources of Pharma Ophthalmic Major Players/Suppliers in 2017
Table Major Buyers of Pharma Ophthalmic
Table Distributors/Traders List
Figure United States Pharma Ophthalmic Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Pharma Ophthalmic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Pharma Ophthalmic Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Pharma Ophthalmic Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Pharma Ophthalmic Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Pharma Ophthalmic Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Pharma Ophthalmic Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Pharma Ophthalmic Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Pharma Ophthalmic Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Pharma Ophthalmic Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Pharma Ophthalmic Sales Volume Share Forecast by Region (2018-2025)
Figure United States Pharma Ophthalmic Sales Volume Share Forecast by Region (2018-2025)
Figure United States Pharma Ophthalmic Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources